We found that BOS significantly inhibited MMP19 induced expression of N-cadherin and vimentin and downregulation of CD31 and VE-cadherin in vitro and in vivo (Fig. 5H–J). This evidence concerns the gene PECAM1 and Buschke-Ollendorff syndrome.